| scholarly article | Q13442814 |
| P2093 | author name string | Azim Nejatizadeh | |
| Fatemeh Mohseni | |||
| Fatemeh Poordarvishi | |||
| Kianoosh Malekzadeh | |||
| Mehrdad Mohtarami | |||
| Minoo Rajaei | |||
| Nasrin Ghashghaeezadeh | |||
| Pooneh Nikuei | |||
| P2860 | cites work | Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis | Q26781355 |
| A lesson for cancer research: placental microarray gene analysis in preeclampsia | Q26827543 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Genetic deletion of placenta growth factor in mice alters uterine NK cells | Q33279374 | ||
| Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. | Q33454185 | ||
| Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia | Q33650241 | ||
| Role of biomarkers in early detection of preeclampsia | Q33783531 | ||
| ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. | Q33990220 | ||
| Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population. | Q34176440 | ||
| The discovery of placenta growth factor and its biological activity. | Q34245619 | ||
| Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia | Q34731047 | ||
| Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction | Q35426799 | ||
| Correlation between cell-free mRNA expressions and PLGF protein level in severe preeclampsia | Q35648869 | ||
| Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies | Q35764454 | ||
| Determinants of placental vascularity | Q35814522 | ||
| Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia | Q35871381 | ||
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma | Q36984261 | ||
| The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome | Q37592279 | ||
| Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14. | Q40767462 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Expression of genes coding for proangiogenic factors and their receptors in human placenta complicated by preeclampsia and intrauterine growth restriction | Q50741892 | ||
| Placental growth factor: a predictive marker for preeclampsia? | Q51734601 | ||
| Placental expression of VEGF family mRNA in adverse pregnancy outcomes. | Q54525786 | ||
| Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy. | Q54600800 | ||
| Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia. | Q54789840 | ||
| Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor | Q56619503 | ||
| First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia | Q56619507 | ||
| PP121. Expression of PlGF, sFlt, MTF-1, HO-1 and HIF-1 alpha mRNAs in preeclampsia placenta and effect of preeclampsia sera on their expression of choriocarcinoma cells | Q56774452 | ||
| Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies | Q57248848 | ||
| The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice | Q64377179 | ||
| Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia | Q73305965 | ||
| Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia | Q73506827 | ||
| Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences | Q79260245 | ||
| Correlations of placental perfusion and PlGF protein expression in early human pregnancy | Q83194284 | ||
| P433 | issue | 3 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | 169-174 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | International Journal of Reproductive Biomedicine (Yazd, Iran) | Q27727296 |
| P1476 | title | Expression of placental growth factor mRNA in preeclampsia | |
| P478 | volume | 15 |
Search more.